體外診斷(IVD)趨勢與市場最新資訊:2024年12月

In Vitro Diagnostic (IVD) Trends and Market Update: December 2024

出版日期: 2024年12月09日 | 出版商:

Kalorama Information | 英文 50 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

在技術進步和不斷擴大的機會的推動下，體外診斷 (IVD) 市場呈現強勁成長。診斷測試正在從簡單地診斷疾病發展到為精準醫學治療提供重要見解。儘管 COVID-19 檢測有所下降，但它繼續對 2024 年的整體收入做出貢獻。受新產品開發、全球醫療保健支出變化、監管變化和疾病趨勢的影響，市場仍充滿活力和彈性。

體外診斷 (IVD) 市場的多個領域正在經歷顯著成長並吸引了行業關注。其中包括即時 (POC) 測試、癌症診斷、伴隨診斷、免疫化學和質譜分析。此外，核酸檢測、基因檢測和 HPV 分子診斷也有望顯著成長，是未來關注的重要領域。

診斷測試現已成為醫療保健的基石，有助於診斷和治療決策。儘管 COVID-19 檢測數量有所下降，但核心診斷領域卻顯示持續成長。市場演變是由創新產品、全球醫療保健成本趨勢、監管變化和新出現的疾病趨勢等因素所驅動的。

主要成長領域包括次世代定序 (NGS)、個人化醫療和質譜。免疫化學、POC 檢測和分子診斷也有望在 IVD 的未來中發揮重要作用。市場的特點是不斷創新和適應。

本報告提供體外診斷(IVD)趨勢與市場最新資訊的相關調查，2024年的市場趨勢與成長促進因素，今後預測等最新洞察。

The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health spending, regulatory changes, and disease trends, maintaining its resilience.

Several segments within the IVD market are experiencing significant growth and attracting industry attention. These include Point-of-Care (POC) testing, cancer diagnostics, companion diagnostics, immunochemistry, and mass spectrometry. Additionally, nucleic acid assays, gene testing, and HPV molecular diagnostics are poised for substantial growth, marking them as key areas of interest for the future.

Diagnostic testing is now a cornerstone of healthcare, aiding in both diagnosis and treatment decisions. Despite the decline in COVID-19 testing, core diagnostic segments have shown consistent growth. The market's evolution is driven by factors such as innovative products, global health expenditure changes, regulatory shifts, and emerging disease trends.

Key growth areas include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, POC testing, and molecular diagnostics are also expected to play crucial roles in the future of IVD. The market is characterized by continuous innovation and adaptation.

The report, "In Vitro Diagnostic (IVD) Trends and Market Update: December 2024" by Kalorama Information provides the latest insights into these trends and other factors shaping the market.

It covers:

Drivers of growth in the IVD market in 2024
Major trends impacting the market in 2024
Product trends and new developments shaping the IVD market in 2024

Highlighted trends from Q3 2023 to Q3 2024 include:

The increasing role of AI technologies in IVD development and testing
Exponential growth in the POC diabetes market
Double-digit growth in HPV molecular testing
Significant growth in blood banking molecular NAT screening due to advancements in nucleic acid method

Chapter 1: Worldwide IVD Market - December 2024 Update

IVD Market Demand and Growth
- Figure 1-1: Q1 2024 - Q3 2024 Segment Performance Commentary
- Table 1-1: Global In Vitro Diagnostic Sales, by Product Market, 2024 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
- Figure 1-2: IVD Segment Performance, Q1 2024 - Q4 2024 estimated ($ million) (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other)
- Figure 1-3: IVD Segment Performance, Total Market Value, 2024 estimated ($ million) (Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, POC, Other)
COVID-19 Diagnostic Markets
- Table 1-2: COVID-19 Product Sales, by Segment, 2024 ($ million) (Immunoassay [Antigen and Serology], Molecular, Rapid [POC Professional and POC At-Home])
Effect of COVID-19 on Market Segments
- Table 1-3: IVD Market excluding and with COVID-19, 2024 ($ million)
- Figure 1-4: IVD Market Distribution, by Segment, 2024 (%) (IVD Market excluding COVID-19 Assays and Instruments, COVID-19 Assays and Instruments)
- Figure 1-5: IVD Market by COVID-19 and non-COVID Markets, Quarterly Performance, Q1 2024 - Q4 2024 estimated ($ million)
- Table 1-4: Global In Vitro Diagnostic Market - YoY Growth, 2023-2024 (%) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
- Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth, 2023-2024 (%) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology [ID/AST]; Microbiology [molecular]; Microbiology - Mass Spectrometry; Coagulation [PT/INR]; Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)

Chapter 2: Product Trends and New Developments

Selected New - Q3 2024 - Core IVD Product Launches, Developments and Trends
Flow Cytometry
Immunoassay
Molecular
Personalized Medicine
POC
Sequencing
Selected COVID-19 Developments - Q3 2024
- Figure 2-1: COVID-19 Test Market, by Type, Q1 2024 - Q4 2024 estimated ($ million) (Antigen, Molecular, Rapid, Serology)
Antigen/Antibody
Molecular

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates
- Figure 3-1: IVD Segment Growth, by Leading Competitors, Change in Sales, 2023-2024 (%) (Abbott Diagnostics, Becton Dickinson, bioMerieux, Danaher, Dexcom, Exact Sciences, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific)
- Figure 3-2: Top 10 IVD Companies: Changes in Market Distribution for IVD Sales, 2021-2024 estimated - Roche and Abbott Battle for #1 Spot (%) (Abbott Diagnostics, Becton Dickinson, bioMerieux, Danaher, Dexcom, Exact Sciences, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific)
- Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2022-2024 ($ million)
Q3 M&A Activity
- Table 3-1: Q3 2024 Merger and Acquisition Activity
Abbott Laboratories
- Table 3-2: Abbott Corporate Summary
Becton Dickinson and Co
- Table 3-3: Becton Dickinson Corporate Summary
bioMerieux SA
- Table 3-4: bioMerieux Corporate Summary
Danaher Corporation
- Table 3-5: Danaher Corporation Summary
Dexcom, Inc.
- Table 3-6: Dexcom Corporate Summary
Exact Sciences
- Table 3-7: Exact Sciences Corporate Summary
Roche Diagnostic
- Table 3-8: Roche Diagnostic Corporate Summary
Siemens Healthineers
- Table 3-9: Siemens Healthineers Corporate Summary
Sysmex Corporation
- Table 3-10: Sysmex Corporate Summary
Thermo Fisher Scientific
- Table 3-11: Thermo Fisher Scientific Corporate Summary